Physician profile
Stuart Haraway
NPI 1073570156
$649.24
in general payments reported to CMS, 2019-2025
13 companies · $69.42 in 2025
The $69.42 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $24.50 · 2021: $21.08 · 2022: $213 · 2023: $61.05 · 2024: $115 · 2025: $69.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $245.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $219.29 | 2019-2023 | |
| Pfizer INC. | $95.87 | 2019-2024 | |
| Organon LLC | $69.42 | 2025 | Nexplanon |
| Meditrina | $67.32 | 2022-2024 | |
| Femselect INC. | $55.68 | 2024 | Enplace |
| Merck Sharp & Dohme LLC | $29.29 | 2019 | |
| Tempus Ai, INC | $27.27 | 2024 | |
| Therapeuticsmd, INC. | $16.47 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.27 | 2019 | |
| Mayne Pharma Commercial LLC | $13.48 | 2023 | |
| Smith+Nephew, INC. | $13.06 | 2023 | Pico 14 |
| Allergan, INC. | $12.93 | 2020 | |
| Covidien Lp | $12.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Haraway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.